Spend Matters Names Zip ‘Foremost’ Leader in “Intake Management: Procurement Tech’s Next Big Market”
New Report Analyzes the Increasingly Critical Role of Intake Management, Market’s Rapid Growth and Evolution…
New Report Analyzes the Increasingly Critical Role of Intake Management, Market’s Rapid Growth and Evolution…
LONDON, Oct 6, 2023 – (ACN Newswire) – In a groundbreaking move that promises to…
London/Edinburgh, Oct 6, 2023 – (ACN Newswire) – Zumo, the UK-based digital-asset-as-a-service platform, has announced…
AI-powered technology will expand access to scans by enabling a broader set of healthcare providers…
SoFi’s Latest Campaign, Featuring LA Chargers Quarterback Justin Herbert, Highlights the Unique Ways It Helps…
Global Perspectives: Data I/O’s CEO Discusses Critical Topics and Emerging Market Trends from Automotive Technologies…
BRAINTREE, Mass.–(BUSINESS WIRE)–M7 Global Partners, a consortium of leading IT consulting firms, today announced the…
SAN DIEGO, Oct. 06, 2023 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a biopharmaceutical…
SAN DIEGO, Oct. 06, 2023 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a biopharmaceutical…
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical…
IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical…
Renowned Daner-Farber Cancer Institute researcher will advise on the development of IMUNON’s FixPlas™ and Indiplas™…
Renowned Daner-Farber Cancer Institute researcher will advise on the development of IMUNON’s FixPlas™ and Indiplas™…
Chief Executive Officer, Amro Albanna to Present at 9:00am Eastern Time on Thursday, October 12,…